NAV
₹10.3600
as on 22 Apr 2019 09:05 PM
₹-0.0610(0.59%)
Last Change
Schemes Managed By
Investment Performance
would have given a returns of
₹100,875
₹101,687
₹100,903
₹101,410
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹1,410
Profit (absolute return)
1.41%
in the last
1m
3m
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
1.41%
In the last 6 months
NA
In the last 1 year
NA
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 22 Apr 2019 09:05 PM
₹183.66 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 12 months.
0.21%
Expense Ratio
Plan
Growth
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 12 months.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Mar 2019
Healthcare
81.42%
₹149.54 Cr
Cash Holding
9.23%
₹16.94 Cr
Financial
5.46%
₹10.03 Cr
Companies Holding in this Mutual Fund
as on 31 Mar 2019
Others
13.12%
₹24.10 Cr
Sun Pharmaceutical Inds. Ltd.
9.62%
₹17.67 Cr
Dr. Reddy's Laboratories Ltd.
7.83%
₹14.38 Cr
Ipca Laboratories Ltd.
7.62%
₹13.99 Cr
Divi's Laboratories Ltd.
5.24%
₹9.62 Cr
JB Chemicals & Pharmaceuticals Ltd.
4.28%
₹7.86 Cr
Unichem Laboratories Ltd.
4.02%
₹7.38 Cr
Indoco Remedies Ltd.
4.01%
₹7.36 Cr
Apollo Hospitals Enterprise Ltd.
3.97%
₹7.29 Cr
Alkem Laboratories Ltd.
3.42%
₹6.28 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Mar 2019
Others
13.12%
₹24.10 Cr
Sun Pharmaceutical Inds. Ltd.
9.62%
₹17.67 Cr
Dr. Reddy's Laboratories Ltd.
7.83%
₹14.38 Cr
Ipca Laboratories Ltd.
7.62%
₹13.99 Cr
Divi's Laboratories Ltd.
5.24%
₹9.62 Cr
JB Chemicals & Pharmaceuticals Ltd.
4.28%
₹7.86 Cr
Unichem Laboratories Ltd.
4.02%
₹7.38 Cr
Indoco Remedies Ltd.
4.01%
₹7.36 Cr
Apollo Hospitals Enterprise Ltd.
3.97%
₹7.29 Cr
Alkem Laboratories Ltd.
3.42%
₹6.28 Cr
View All
View All
This fund's returns:
1.41%Return Duration
3 Months
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Invesment
₹500
Category Returns
-1.41%
4.43%
3M Returns
4.43
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Invesment
₹100
Category Returns
-1.41%
4.43%
3M Returns
3.61
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Invesment
₹1000
Category Returns
-1.41%
4.43%
3M Returns
2.61
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on 30 Nov 2018 and is currently managed by its fund managers Vinit Sambre, Jay Kothari and Aditya Khemka. It has an AUM of ₹183.66 Crores and the latest NAV decalared is ₹10.360 as on 22 Apr 2019 at 9:05 pm.
DSP Healthcare Fund Direct - Growth scheme return performance is 3.04% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
AMC Information
DSP Mutual Fund
View AMC Details
₹76,439.14 Cr
AUM
99
Schemes
Address
NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road JunctionWestern Express Highway,Andheri East400069
Phone Number
Phone : 022-66178000
Fax : 022-5657 8181
Email / Website